Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384461034> ?p ?o ?g. }
- W4384461034 abstract "Abstract Traumatic brain injury (TBI) is associated with a hyperadrenergic state and paradoxically causes systemic bone loss while accelerating fracture healing. Here, we identify the beta2-adrenergic receptor (Adrb2) as a central mediator of these skeletal manifestations. While the negative effects of TBI on the unfractured skeleton can be explained by the established impact of Adrb2 signaling on bone formation, Adrb2 promotes neovascularization of the fracture callus under conditions of high sympathetic tone, including TBI and advanced age. Mechanistically, norepinephrine stimulates the expression of Vegfa and Cgrp primarily in periosteal cells via Adrb2, both of which synergistically promote the formation of osteogenic type-H vessels in the fracture callus. Accordingly, the beneficial effect of TBI on bone repair is abolished in mice lacking Adrb2 or Cgrp, and aged Adrb2-deficient mice without TBI develop fracture nonunions despite high bone formation in uninjured bone. Pharmacologically, the Adrb2 antagonist propranolol impairs, and the agonist formoterol promotes fracture healing in aged mice by regulating callus neovascularization. Clinically, intravenous beta-adrenergic sympathomimetics are associated with improved callus formation in trauma patients with long bone fractures. Thus, Adrb2 is a novel target for promoting bone healing, and widely used beta-blockers may cause fracture nonunion under conditions of increased sympathetic tone. Abstract Figure Artwork was created in BioRender." @default.
- W4384461034 created "2023-07-16" @default.
- W4384461034 creator A5014708437 @default.
- W4384461034 creator A5019664542 @default.
- W4384461034 creator A5026700318 @default.
- W4384461034 creator A5027496638 @default.
- W4384461034 creator A5027778171 @default.
- W4384461034 creator A5037672833 @default.
- W4384461034 creator A5038463012 @default.
- W4384461034 creator A5038947883 @default.
- W4384461034 creator A5040226489 @default.
- W4384461034 creator A5043736390 @default.
- W4384461034 creator A5046095613 @default.
- W4384461034 creator A5046719684 @default.
- W4384461034 creator A5060854520 @default.
- W4384461034 creator A5062409721 @default.
- W4384461034 creator A5064391109 @default.
- W4384461034 creator A5069236094 @default.
- W4384461034 creator A5084561227 @default.
- W4384461034 creator A5084674862 @default.
- W4384461034 creator A5085531095 @default.
- W4384461034 creator A5088591482 @default.
- W4384461034 creator A5089655169 @default.
- W4384461034 creator A5090337349 @default.
- W4384461034 creator A5092479128 @default.
- W4384461034 creator A5092479129 @default.
- W4384461034 creator A5092479130 @default.
- W4384461034 creator A5092479131 @default.
- W4384461034 creator A5092479132 @default.
- W4384461034 date "2023-07-16" @default.
- W4384461034 modified "2023-10-17" @default.
- W4384461034 title "Increased beta2-adrenergic signaling is a targetable stimulus essential for bone healing by promoting callus neovascularization" @default.
- W4384461034 cites W1769990193 @default.
- W4384461034 cites W1963690512 @default.
- W4384461034 cites W1974472801 @default.
- W4384461034 cites W1976837794 @default.
- W4384461034 cites W1980751002 @default.
- W4384461034 cites W1988160703 @default.
- W4384461034 cites W1988425215 @default.
- W4384461034 cites W1997331484 @default.
- W4384461034 cites W1997508587 @default.
- W4384461034 cites W2026370012 @default.
- W4384461034 cites W2026898863 @default.
- W4384461034 cites W2028448521 @default.
- W4384461034 cites W2036728117 @default.
- W4384461034 cites W2039041739 @default.
- W4384461034 cites W2046882967 @default.
- W4384461034 cites W2052520062 @default.
- W4384461034 cites W2064344765 @default.
- W4384461034 cites W2066749771 @default.
- W4384461034 cites W2089254126 @default.
- W4384461034 cites W2121497606 @default.
- W4384461034 cites W2136163260 @default.
- W4384461034 cites W2138207763 @default.
- W4384461034 cites W2144409619 @default.
- W4384461034 cites W2147510409 @default.
- W4384461034 cites W2159733957 @default.
- W4384461034 cites W2166403437 @default.
- W4384461034 cites W2169456326 @default.
- W4384461034 cites W2179438025 @default.
- W4384461034 cites W2261324366 @default.
- W4384461034 cites W2274542647 @default.
- W4384461034 cites W2346717329 @default.
- W4384461034 cites W2514979671 @default.
- W4384461034 cites W2535626658 @default.
- W4384461034 cites W2550062403 @default.
- W4384461034 cites W2591558715 @default.
- W4384461034 cites W2615201841 @default.
- W4384461034 cites W2754904662 @default.
- W4384461034 cites W2777618713 @default.
- W4384461034 cites W2792575045 @default.
- W4384461034 cites W2900419127 @default.
- W4384461034 cites W2902526020 @default.
- W4384461034 cites W2902901095 @default.
- W4384461034 cites W2906678538 @default.
- W4384461034 cites W2926911577 @default.
- W4384461034 cites W2957376989 @default.
- W4384461034 cites W2972736963 @default.
- W4384461034 cites W2986984753 @default.
- W4384461034 cites W2991150034 @default.
- W4384461034 cites W2998687291 @default.
- W4384461034 cites W3003762576 @default.
- W4384461034 cites W3080391597 @default.
- W4384461034 cites W3122373999 @default.
- W4384461034 cites W3174089653 @default.
- W4384461034 cites W3189146210 @default.
- W4384461034 cites W3195195170 @default.
- W4384461034 cites W3196998437 @default.
- W4384461034 cites W3197511911 @default.
- W4384461034 cites W4211221406 @default.
- W4384461034 cites W4223519274 @default.
- W4384461034 cites W4256444410 @default.
- W4384461034 cites W4280530929 @default.
- W4384461034 cites W4283740529 @default.
- W4384461034 cites W4313825596 @default.
- W4384461034 cites W4318827356 @default.
- W4384461034 cites W996178345 @default.
- W4384461034 doi "https://doi.org/10.1101/2023.07.14.548550" @default.
- W4384461034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37502964" @default.
- W4384461034 hasPublicationYear "2023" @default.